Fugitive diamond merchant Nirav Modi, fighting extradition to India on charges over the nearly £2 billion Punjab National Bank (PNB) fraud and money laundering case, was produced for a regular remand hearing at Westminster Magistrates’ Court in London on Thursday (30) and further remanded in custody until February 27.
The 48-year-old, who has been lodged at Wandsworth Prison in south-west London, appeared via videolink from prison before District Judge David Robinson.
“I am told that your case is proceeding in accordance with the directions for a final hearing on 11 May,” the judge told Modi, as he set the next 28-day remand hearing via videolink for February 27.
Modi’s extradition trial is scheduled for five days starting May 11, with the case management hearings in the case set to begin once all the evidence has been handed in to the court for the trial.
He had made a last-ditch bail application in November last year with an “unprecedented” house arrest guarantee, akin to those imposed on terrorist suspects, as well as citing mental health issues from being behind bars at Wandsworth since his arrest in March 2019.
But the bail plea was turned down by Chief Magistrate Emma Arbuthnot over continued fears of witness intimidation and failure to surrender before the court for his extradition trial this year.
The UK’s Crown Prosecution Service (CPS), which represents the Indian government in the extradition proceedings, said there is no further prospect of an appeal for bail in a higher court as the UK High Court had already turned down Modi’s plea earlier last year.
Modi is meanwhile expected to appear for “call-over” hearings every 28 days at Westminster Magistrates'' Court until the case management hearings for his extradition trial kick in.
The diamond merchant denies the charges of fraud and money laundering and his defence team, led by barrister Hugo Keith, has claimed that the Indian government has wrongly “blackened” Modi’s name as a “world-class schemer”.
As part of the change in circumstances required for a fresh bail application, Modi’s lawyers had offered to double the bail bond security offered to the court, from the previous £2 million to £4 million. They had also informed the court of attacks on their client from fellow inmates at one of England’s most overcrowded prisons.
Modi has been behind bars at Wandsworth since his arrest on March 19 on an extradition warrant executed by Scotland Yard on charges brought by the Indian government. During subsequent hearings, the UK court has been told that Modi was the "principal beneficiary" of the fraudulent issuance of letters of undertaking (LoUs) as part of a conspiracy to defraud PNB and then laundering the proceeds of crime.
His extradition trial is scheduled between May 11 and 15 this year.
Veterinary practices ordered to publish price lists and disclose corporate ownership under new CMA proposals.
Pet healthcare costs have risen at nearly twice the rate of inflation, investigation finds.
CVS Group shares surge 18 per cent as market welcomes lack of direct price controls on medicines.
Watchdog pushes for price transparency
Britain’s competition watchdog has provisionally ordered veterinary practices to publish price lists and disclose corporate ownership, aiming to give pet owners greater transparency in a sector where costs have risen at nearly twice the rate of inflation.
The Competition and Markets Authority (CMA) said on Wednesday (15) that pet owners are often unaware of prices or not given estimates for treatments that can run into thousands of pounds.
Under the proposed measures, vet businesses must publish prices for common procedures and make clear which practices are independent and which belong to large corporate chains. The watchdog also plans to cap prescription fees and ban bonuses linked to specific treatments.
“We believe that the measures we are proposing would be beneficial to the sector as a whole, including vets and vet nurses,” the CMA stated in its provisional decision report. “Providing better information for pet owners will increase their confidence in vet businesses and the profession.”
Industry reactions
The announcement triggered immediate market reactions. Bloomberg reported Shares of CVS Group, a British veterinary services provider, rose as much as 18 per cent in early London trading before paring gains, whilst Pets at Home traded up to 4.9 per cent higher. Both companies had underperformed since the CMA launched its investigation.
“While the tone of the CMA’s report is sharp, we see few surprises versus our expectations,” said Jefferies analyst Andrew Wade to Bloomberg. “The lack of pricing controls on services notably medicines must be viewed as a positive.”
The veterinary profession offered cautious support for the reforms. Dr Rob Williams, president of the British Veterinary Association, said: “At first glance, there’s lots of positives in the CMA’s provisional decision that both vets and pet owners will welcome, including greater transparency of pricing and practice ownership."
However, animal welfare charities warned of the consequences when pet owners delay treatment due to cost concerns. Caroline Allen, the RSPCA’s Chief Veterinary Officer, told BBC “Our frontline officers sadly see first-hand the consequences when people delay or avoid seeking professional help, or even attempt to treat conditions themselves."
The proposed remedies package also includes requirements for vet businesses to improve complaint processes and conduct regular customer satisfaction surveys comparing large groups with independent practices. Additionally, practices would find it easier to terminate out-of-hours contracts with third-party providers if better alternatives exist.
The CMA emphasised that vet businesses failing to comply, or those pressuring veterinarians to act in certain ways or sell specific treatments, could be in breach of the Order.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.